The Medicines Company to Announce Second Quarter 2019 Financial Results on July 24

17 Jul 2019

The Medicines Company (NASDAQ: MDCO) will host a conference call and audio webcast on Wednesday, July 24, 2019 at 8:30 a.m. EDT to discuss its second quarter 2019 financial results and operational developments.

The conference call may be accessed by telephone as follows:

       

U.S./Canada:

     

(877) 407-0312

       

International:

     

(201) 389-0899

       

Conference ID:

     

13692457

A live audio webcast of the conference call may be accessed in the Investors section of The Medicines Company website.

A taped replay of the conference call will be available after the call concludes, and may be accessed by telephone as follows:

     

U.S./Canada:

     

(877) 660-6853

     

International:

     

(201) 612-7415

     

Conference ID:

     

13692457

An archived webcast will be also be available after the call concludes.

About The Medicines Company

The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. Our team is focused on transformational solutions that address the daily challenges that patients, physicians and payers confront in cardiovascular care. The Company is headquartered in Parsippany, New Jersey. For more information, please visit www.themedicinescompany.com and follow us on Twitter @MDCONews and LinkedIn.

Join $MDCO on Wed, Jul 24 for 2Q 2019 financial results and operational developments. Conference call & audio webcast to begin at 8:30 AM EDT.

Contact Us

The Medicines Company
8 Sylvan Way
Parsippany, NJ 07054 USA
Tel 973 290 6000
Toll-free 800 388 1183
Global Medical Information

Human Resources
Verification of employment
Tel 973 290 6361
Fax 862 207 6361

Investors Relations

Krishna Gorti, MD
Tel 973 290 6122
krishna.gorti@themedco.com

Media Inquiries

Michael Blash
Tel 973 290 6100
michael.blash@themedco.com